Ascendis Pharma A/S (ASND)
NASDAQ·Healthcare·Biotechnology
$253.58
-0.34%
Mkt Cap $14.73B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (43 analysts)
$287.50
Range $250.00 – $345.00
Implied Upside
+13.4%
Consensus $287.50 vs current $253.58
NASDAQ·Healthcare·Biotechnology
$253.58
-0.34%
Mkt Cap $14.73B
Buy
9
Hold
0
Sell
0
Price Target (43 analysts)
$287.50
Range $250.00 – $345.00
+13.4%
Consensus $287.50 vs current $253.58